North America Omega 3 & Structured lipids (Nutraceuticals) Market By Application (Functional food, Functional Beverages, Animal Feed, Dietary Supplements, Personal care ) and By Geography- Trends and Forecast upto 2019
The North American Omega-3 & structured lipids (nutraceuticals) market is projected to grow at a CAGR of 6.6% from 2014 to 2019. The rapid rate of globalization in the developing countries of North America is boosting the food & beverage industry. The increasing disposable income in these countries has caused an upsurge in the demand for functional foods & beverages. Countries such as the U.S. and Canada have strong nutraceuticals and functional food & drinks sectors, in contrast with countries such as Mexico, which are gradually growing. In other parts of North America, this sector is still in its nascent stage, mainly due to the lack of awareness of these products.
In this report, the North American Omega-3 & structured lipids (nutraceuticals) market has been broadly discussed by its applications such as functional food, functional beverages, dietary supplement, animal feed, and personal care. The dietary supplements segment is projected to grow at the highest CAGR from 2014 to 2019.
The U.S. is the largest Omega-3 & structured lipids (nutraceuticals) market in North America, with a share of 54.94%, followed by Canada and Mexico. Increase in consumer awareness has propelled the demand for Omega-3 & structured lipids products in this region.
BASF SE (Germany) has a major share in the North American Omega-3 & structured lipids (nutraceuticals) market. Nippon Suisan Kaisha (NISSUI) (Japan), with a market share of 7.02% is not far behind. Other firms such as Wuxi Xunda (China) and Croda International (U.K.) are competing in the region. These companies are engaged in mergers & acquisitions, joint ventures, new product development, and expansions to increase their share in the North American Omega-3 & structured lipids (nutraceuticals) market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis, market share analysis of top players, company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the North American Omega 3 & structured lipids (nutraceuticals) market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enable both, established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn, will help them in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
In this report, the North American Omega-3 & structured lipids (nutraceuticals) market has been broadly discussed by its applications such as functional food, functional beverages, dietary supplement, animal feed, and personal care. The dietary supplements segment is projected to grow at the highest CAGR from 2014 to 2019.
The U.S. is the largest Omega-3 & structured lipids (nutraceuticals) market in North America, with a share of 54.94%, followed by Canada and Mexico. Increase in consumer awareness has propelled the demand for Omega-3 & structured lipids products in this region.
BASF SE (Germany) has a major share in the North American Omega-3 & structured lipids (nutraceuticals) market. Nippon Suisan Kaisha (NISSUI) (Japan), with a market share of 7.02% is not far behind. Other firms such as Wuxi Xunda (China) and Croda International (U.K.) are competing in the region. These companies are engaged in mergers & acquisitions, joint ventures, new product development, and expansions to increase their share in the North American Omega-3 & structured lipids (nutraceuticals) market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis, market share analysis of top players, company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the North American Omega 3 & structured lipids (nutraceuticals) market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enable both, established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn, will help them in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on Omega-3 & structured lipids (nutraceuticals) offered by the top 10 players in the North American market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the North American Omega-3 & structured lipids (nutraceuticals) market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various applications of Omega-3 & structured lipids (nutraceuticals) across North America.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the North American Omega-3 & structured lipids (nutraceuticals) market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the North American Omega-3 & structured lipids (nutraceuticals) market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
2.2 ARRIVING AT THE OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 DEMAND-SIDE APPROACH
2.2.3 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
4.5 DEMAND-SIDE ANALYSIS
5 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN FUNCTIONAL FOOD, BY GEOGRAPHY
5.3 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY
5.4 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN DIETARY SUPPLEMENTS, BY GEOGRAPHY
5.5 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN ANIMAL FEED, BY GEOGRAPHY
5.6 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN PERSONAL CARE, BY GEOGRAPHY
5.7 SNEAK VIEW: NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS), BY APPLICATION
6 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
6.2.1 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
6.3 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
6.3.1 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
6.4 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
6.4.1 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
7 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPETITIVE LANDSCAPE
7.1 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSION
7.4 INVESTMENTS AND NEW PRODUCT DEVELOPMENTS
8 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 BASF SE
8.2 NIPPON SUISAN KAISHA LTD.
8.3 WUXI XUNDA MARINE BIOLOGICAL PRODUCTS CO., LTD.
8.4 CRODA INTERNATIONAL PLC
8.5 GC RIEBER GROUP
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 PRODUCT TYPE ASSISTANCE
9.1.2 SUPPLY CHANNEL ANALYSIS
9.1.3 MARKET TRENDS
9.1.4 COMPETITIVE INTELLIGENCE
9.1.5 REAL-TIME UPDATES
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
2.2 ARRIVING AT THE OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 DEMAND-SIDE APPROACH
2.2.3 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
4.5 DEMAND-SIDE ANALYSIS
5 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN FUNCTIONAL FOOD, BY GEOGRAPHY
5.3 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY
5.4 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN DIETARY SUPPLEMENTS, BY GEOGRAPHY
5.5 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN ANIMAL FEED, BY GEOGRAPHY
5.6 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) IN PERSONAL CARE, BY GEOGRAPHY
5.7 SNEAK VIEW: NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS), BY APPLICATION
6 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
6.2.1 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
6.3 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
6.3.1 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
6.4 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET
6.4.1 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION
7 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPETITIVE LANDSCAPE
7.1 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSION
7.4 INVESTMENTS AND NEW PRODUCT DEVELOPMENTS
8 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 BASF SE
8.2 NIPPON SUISAN KAISHA LTD.
8.3 WUXI XUNDA MARINE BIOLOGICAL PRODUCTS CO., LTD.
8.4 CRODA INTERNATIONAL PLC
8.5 GC RIEBER GROUP
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 PRODUCT TYPE ASSISTANCE
9.1.2 SUPPLY CHANNEL ANALYSIS
9.1.3 MARKET TRENDS
9.1.4 COMPETITIVE INTELLIGENCE
9.1.5 REAL-TIME UPDATES
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
LIST OF TABLES
TABLE 1 GLOBAL OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) PEER MARKET SIZE, 2014 (USD MN)
TABLE 2 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) APPLICATION MARKET, 2014 (TONS)
TABLE 3 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: MACRO INDICATORS, BY GEOGRAPHY, 2014 (ABSOLUTE)
TABLE 4 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (USD MN)
TABLE 5 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (TONS)
TABLE 6 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: DRIVERS AND INHIBITORS
TABLE 7 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 8 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 9 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH APPLICATION MARKETS, 2013 - 2019 (USD MN)
TABLE 10 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 11 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 12 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL FOOD, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 13 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL FOOD, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 14 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 15 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 16 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN DIETARY SUPPLEMENTS, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 17 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN DIETARY SUPPLEMENTS, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 18 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN ANIMAL FEED, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 19 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN ANIMAL FEED, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 20 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN PERSONAL CARE, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 21 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN PERSONAL CARE, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 22 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 23 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 24 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 25 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013-2019 (TONS)
TABLE 26 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 27 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 28 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 29 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 30 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPANY SHARE ANALYSIS, 2014(%)
TABLE 31 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: MERGERS & ACQUISITIONS
TABLE 32 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: EXPANSIONS
TABLE 33 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: INVESTMENTS AND NEW PRODUCT DEVELOPMENTS
TABLE 34 BASF SE: KEY OPERATIONS DATA, EBIT, 2009 - 2013 (USD MN)
TABLE 35 BASF SE: KEY FINANCIALS, 2010 - 2014 (USD MN)
TABLE 36 NIPPON SUISAN KAISHA LTD. KEY OPERATIONS DATA, 2009 - 2013 (USD MN)
TABLE 37 NIPPON SUISAN KAISHA LTD.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 38 CRODA INTERNATIONAL PLC: KEY OPERATIONAL DATA, 2009 - 2013 (USD MN)
TABLE 39 GC RIEBER GROUP KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 1 GLOBAL OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) PEER MARKET SIZE, 2014 (USD MN)
TABLE 2 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) APPLICATION MARKET, 2014 (TONS)
TABLE 3 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: MACRO INDICATORS, BY GEOGRAPHY, 2014 (ABSOLUTE)
TABLE 4 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (USD MN)
TABLE 5 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (TONS)
TABLE 6 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: DRIVERS AND INHIBITORS
TABLE 7 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 8 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 9 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPARISON WITH APPLICATION MARKETS, 2013 - 2019 (USD MN)
TABLE 10 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 11 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 12 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL FOOD, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 13 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL FOOD, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 14 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 15 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 16 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN DIETARY SUPPLEMENTS, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 17 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN DIETARY SUPPLEMENTS, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 18 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN ANIMAL FEED, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 19 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN ANIMAL FEED, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 20 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN PERSONAL CARE, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 21 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN PERSONAL CARE, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 22 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN)
TABLE 23 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY GEOGRAPHY, 2013 - 2019 (TONS)
TABLE 24 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 25 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013-2019 (TONS)
TABLE 26 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 27 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 28 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
TABLE 29 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
TABLE 30 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPANY SHARE ANALYSIS, 2014(%)
TABLE 31 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: MERGERS & ACQUISITIONS
TABLE 32 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: EXPANSIONS
TABLE 33 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: INVESTMENTS AND NEW PRODUCT DEVELOPMENTS
TABLE 34 BASF SE: KEY OPERATIONS DATA, EBIT, 2009 - 2013 (USD MN)
TABLE 35 BASF SE: KEY FINANCIALS, 2010 - 2014 (USD MN)
TABLE 36 NIPPON SUISAN KAISHA LTD. KEY OPERATIONS DATA, 2009 - 2013 (USD MN)
TABLE 37 NIPPON SUISAN KAISHA LTD.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 38 CRODA INTERNATIONAL PLC: KEY OPERATIONAL DATA, 2009 - 2013 (USD MN)
TABLE 39 GC RIEBER GROUP KEY FINANCIALS, 2009 - 2013 (USD MN)
LIST OF FIGURES
FIGURE 1 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: SEGMENTATION & COVERAGE
FIGURE 2 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 RESEARCH METHODOLOGY
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DEMAND SIDE APPROACH
FIGURE 6 MACRO INDICATOR-BASED APPROACH
FIGURE 7 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET SNAPSHOT
FIGURE 8 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: GROWTH ASPECTS
FIGURE 9 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2014 VS. 2019
FIGURE 10 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS): KEY APPLICATION MARKET SCENARIO
FIGURE 11 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
FIGURE 12 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
FIGURE 13 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL FOOD, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 14 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 15 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN DIETARY SUPPLEMENTS, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 16 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN ANIMAL FEED, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 17 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN PERSONAL CARE, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 18 SNEAK VIEW: NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET (VALUE)
FIGURE 19 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2014 - 2019(USD MN)
FIGURE 20 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2013-2019 (TONS)
FIGURE 21 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 22 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013-2019 (USD MN)
FIGURE 23 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: APPLICATION SNAPSHOT
FIGURE 24 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 25 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
FIGURE 26 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: APPLICATION SNAPSHOT
FIGURE 27 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 28 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS)MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
FIGURE 29 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: APPLICATION SNAPSHOT
FIGURE 30 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
FIGURE 31 BASF SE: REVENUE MIX, 2013 (%)
FIGURE 32 NIPPON SUISAN KAISHA LTD. REVENUE MIX, 2014 (%)
FIGURE 33 CRODA INTERNATIONAL PLC REVENUE MIX, 2013 (%)
FIGURE 1 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: SEGMENTATION & COVERAGE
FIGURE 2 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 RESEARCH METHODOLOGY
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DEMAND SIDE APPROACH
FIGURE 6 MACRO INDICATOR-BASED APPROACH
FIGURE 7 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET SNAPSHOT
FIGURE 8 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: GROWTH ASPECTS
FIGURE 9 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2014 VS. 2019
FIGURE 10 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS): KEY APPLICATION MARKET SCENARIO
FIGURE 11 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
FIGURE 12 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (TONS)
FIGURE 13 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL FOOD, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 14 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN FUNCTIONAL BEVERAGES, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 15 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN DIETARY SUPPLEMENTS, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 16 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN ANIMAL FEED, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 17 NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET IN PERSONAL CARE, BY GEOGRAPHY, 2013 - 2019 (USD MN)
FIGURE 18 SNEAK VIEW: NORTH AMERICA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET (VALUE)
FIGURE 19 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2014 - 2019(USD MN)
FIGURE 20 NORTH AMERICAN OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2013-2019 (TONS)
FIGURE 21 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 22 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013-2019 (USD MN)
FIGURE 23 U.S. OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: APPLICATION SNAPSHOT
FIGURE 24 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 25 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
FIGURE 26 CANADA OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: APPLICATION SNAPSHOT
FIGURE 27 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 28 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS)MARKET, BY APPLICATION, 2013 - 2019 (USD MN)
FIGURE 29 MEXICO OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: APPLICATION SNAPSHOT
FIGURE 30 OMEGA-3 & STRUCTURED LIPIDS (NUTRACEUTICALS) MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
FIGURE 31 BASF SE: REVENUE MIX, 2013 (%)
FIGURE 32 NIPPON SUISAN KAISHA LTD. REVENUE MIX, 2014 (%)
FIGURE 33 CRODA INTERNATIONAL PLC REVENUE MIX, 2013 (%)
